Market Place
Sourcing Support
All News #Library
Others
Excision BioTherapeutics Awarded a “Fierce 15” Biotech Company of 2024
05 Aug 2024 //
GLOBENEWSWIRE
Excision BioTherapeutics Announces ASGCT 2024 Presentations
10 Apr 2024 //
GLOBENEWSWIRE
Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV
20 Oct 2022 //
GLOBENEWSWIRE
Excision Awarded (CIRM) Grant to Support Ongoing Ph1/2 Trial EBT-101
29 Sep 2022 //
GLOBENEWSWIRE
Excision doses first subject in Phase I/II HIV therapeutic trial
16 Sep 2022 //
CLINICALTRIALSARENA
Excision BioTherapeutics Doses First Participant in EBT-101 Ph 1/2 Trial EBT-101
15 Sep 2022 //
GLOBENEWSWIRE
Excision BioTherapeutics to Present at Upcoming Conferences
09 Sep 2022 //
GLOBENEWSWIRE
Excision Bio to Participate in the Jefferies Healthcare Conference
07 Jun 2022 //
GLOBENEWSWIRE
Excision BioTherapeutics to Present Preclinical & Bioinformatic Data on EBT-101
17 May 2022 //
GLOBENEWSWIRE
Moderna hits the gas as it begins dosing of 2nd HIV vaccine
15 Mar 2022 //
FIERCEBIOTECH
Moderna, Excision each enter HIV battle with mRNA, CRISPR tech
27 Jan 2022 //
FIERCEBIOTECH
Excision Initiates Phase 1/2 Trial Evaluating EBT-101 as Cure for HIV
27 Jan 2022 //
GLOBENEWSWIRE
GSK downsizes office space with new locations in Philly, NC
06 Oct 2021 //
FIERCEPHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.